スポンサーリンク
Information Science Center Of Nippon Medical School | 論文
- Use of Intravenous Dofetilide in Atrial Flutter With Hemodynamic Instability
- EFFECTS OF ELECTRICALLY INDUCED VENTRICULARPREMATURE CONTRACTION ON HEART RATEVARIABILITY SPECTRAL ANALYSIS
- -122-ELECTROPHYSIOLOGIC AND HEMODYNAMIC EFFECTS OF SUN 1165 : A NEW ANTIARRHYTHMIC DRUG : Cardiovascular Drugs : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- -1026-ACUTE EFFECTS OF ANTIARRHYTHMICS ON THE LOW AMPLITUDE HIGH FREQUENCY SIGNALS IN QRS COMPLEX : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- 回転する図形を注視した際の重心動揺に関する研究
- 重心動揺とマイクロバイブレーションの周波数解析による比較検討
- 神経疾患患者における重心動揺のランダム性の検討
- 情動負荷時の末梢皮膚血流の事象関連変動
- α-ADRENERGIC FUNCTION IN THE PATIENTS WITH CARDIAC ARRHYTHMIA : WITH REFFERENCE TO THE SYMPTOMS RELATED TO CEREBRAL ISCHEMIA
- Uncommon Atrial Flutter Originating in the Left Atrioventricular Groove : Emergence After Successful Catheter Ablation for a Left Concealed Accessory Pathway
- Detection of a Local Slow Potential Preceding the Surface QRS Complex During Non-Preexcited Impulse Propagation : A Phenomenon Reflecting Anterograde Concealed Conduction Through the Accessory Pathway?
- 0325 EPIDEMIOLOGIC ASSESSMENT AND NATURAL HISTORY OF ATRIAL FIBRILLATION IN A POPULATION-BASED 29000 SUBJECTS FROM INDUSTRIAL MEDICAL EXAMINATION
- From paroxysmal atrial fibrillatio (PAF) to chronic atrial fibrillation (AF) : Risk factors and preventing effects of drug therapy
- AUTONOMIC NEURAL MODULATION OF ATRIOVENTRICULAR CONDUCTION TIME ANALYZED BY SPECTRAL ANALYSIS
- -P248- THE ELECTROPHYSIOLOGIC SIGNIFICANCE OF DOUBLE POTENTIAL(DP)RECORDED IN THE CORONARY SINUS(CS)DURING ATRIO-VENTRICULAR REENTRANT TACHYCARDIA(AVRT)(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- ACUTE HEMODYNAMIC AND ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS PILSICAINIDE
- EFFECT OF INTRAVENOUS APRINDINE ON VARIOUS ARRHYTHMIAS : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Cardiovascular Drugs (II)